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Enlarged vestibular aqueduct (EVA) syndrome is a common congenital inner ear malformation characterized by a vestibular
aqueduct with a diameter larger than 1.5mm,mixed or sensorineural hearing loss that ranges frommild to profound, and vestibular
disorders that may be present with a range from mild imbalance to episodic objective vertigo. In our study, we present the case
of a patient with unilateral enlarged vestibular aqueduct and bilateral endolymphatic hydrops (EH). EH was confirmed through
anamnestic history and audiological exams; EVAwas diagnosed using high-resolution CT scans andMRI images.Therapy included
intratympanic infusion of corticosteroids with a significant hearing improvement, more evident in the ear contralateral to EVA.
Although most probably unrelated, EVA and EH may present with similar symptoms and therefore the diagnostic workup should
always include the proper steps to perform a correct diagnosis. Association between progression of hearing loss and head trauma
in patients with a diagnosis of EVA syndrome is still uncertain; however, these individuals should be advised to avoid activities
that increase intracranial pressure to prevent further hearing deterioration. Intratympanic treatment with steroids is a safe and
well-tolerated procedure that has demonstrated its efficacy in hearing, tinnitus, and vertigo control in EH.
1. Introduction
In adults, the vestibular aqueduct presents a diameter of
0.4–1.0mm, with a mean value of 0.62mm [1, 2]. Enlarged
Vestibular Aqueduct (EVA), one of the most common con-
genital inner earmalformations, is characterized by a vestibu-
lar aqueduct with an anteroposterior diameter of 1.5mm or
more, measured halfway between the common crus and the
operculum [3].
Clinical presentation includes audiological and vestibular
symptoms that often mimic those of other middle and inner
ear disorders such as otosclerosis [4, 5] and endolymphatic
hydrops (EH) [6]. Mixed or sensorineural hearing loss
(SNHL) is reported in 59–94% of cases, often associated with
tinnitus and aural fullness. Hearing loss ranges from mild to
profound, varying from fluctuating to progressive or sudden
[7–11]; hearing fluctuations may happen following relatively
minor head trauma. Mixed hearing loss may be supported by
the hypothesis that an EVA introduces a thirdmobile window
into the inner ear [12]. Vestibular symptoms in patients with
an EVA syndrome have a prevalence between 14 and 73%
depending on the study [7, 13–15] and range from severe
episodic vertigo to occasional unsteadiness in adults, whereas
incoordination and imbalance predominate in children [7, 16,
17].
Diagnosis of EVA syndrome is radiological. Computed
Tomography (CT) scan shows the bony labyrinth anatomy,
and an axial CT with 1.5-mm sections generally provides the
best view of the vestibular aqueduct from the vestibule to the
posterior surface of the petrous bone [8, 18]. Magnetic Res-
onance Imaging (MRI), especially on T2-weighted images,
allows visualization of the membranous labyrinth [13, 14, 19]
and is the only imaging technique that enables visualization
of the extraosseous portion of the endolymphatic sac. Three-
dimensional reconstructions from MRI data sets are often
helpful in detecting the sac and other inner ear structures and
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to better define their morphological features, so that MRI is
considered superior toCT inEVAevaluation by some authors
[20, 21].
No treatment protocol for EVA syndrome was demon-
strated to be uniformly successful in halting the progression
of the disease; cochlear implantation is the optimal solution
for hearing loss restoration when profound hearing loss is
present [19].
Intratympanic corticosteroid treatment for inner ear
diseases by direct injection in the middle ear has gained
wide popularity in the last years [22–25], presenting several
benefits such as an increased drug concentration in the
target organ, reduced systemic steroid exposure, and reduced
systemic adverse effects. The effects of inner ear corticos-
teroid therapy are based on their anti-inflammatory and
immunosuppressive actions in addition to their regulatory
role in ionic homeostasis as they act on potassium transport,
improving the inner ear water balance [26].
Many audiovestibular symptoms found in EVA syndrome
are in common with other inner ear disorders such as EH;
differential diagnosis is therefore important for a correct
diagnostic and therapeutic management of these patients. In
this paper, we describe the case of a patient with a history of
bilateral EH and a radiological diagnosis of EVA in the left ear,
along with a detailed description of the diagnostic workup
and therapeutic approach.
2. Case Presentation
A 39-year-old man was admitted to the ENT department of
our institution with a four-year history of fluctuating bilateral
SNHL, associated with acute objective vertigo, nausea, and
vomit (4–8 episodes/year); the vertigo attacks, lasting from 15
minutes to three hours, were often accompanied by headache.
The patient had no history of acoustic trauma and/or noise
exposure and had a previous glycerol test positive for EH.
After admission, patient underwent a complete ENT
examination with otoscopy, Pure Tone Audiometry (PTA),
Acoustic Immittance Test, Transient Evoked Otoacous-
tic Emissions (TEOAEs), Distortion Products Otoacoustic
Emissions (DPOAEs), Tympanometry, Cervical Vestibular
Evoked Myogenic Potentials (cVEMPs), and caloric test.
PTA was carried out in a soundproof room and the pure
tone thresholds for each side were measured at frequencies
of 125, 250, 500, 750, 1000, 2000, 3000, 4000, 6000, and
8000Hz; Air-Bone Gap (ABG) was measured at frequencies
of 250, 500, 1000, 2000, and 4000Hz. A standard 226Hz tone
tympanometry probe was performed to exclude external and
middle ear pathologies. TEOAEs andDPOAEswere recorded
in a sound attenuated chamber with an ILO-92 instrument
(Amplifon, Milan, Italy). TEOAEs were evoked through
80–85 dB SPL stimuli, with a stimulation rate less than 60
stimuli per second, delivered through a probe inserted into
the external auditory canal. DPOAEs were recorded with
two acoustic stimuli (pure tones) at two frequencies (i.e.,
𝑓1, 𝑓2 [𝑓2 > 𝑓1]) and two intensity levels (i.e., 𝐿1, 𝐿2).
cVEMPs were tested with the binaural simultaneous stimula-
tion method, using an Amplaid MK22 polygraph (Amplifon,
Milan, Italy). The electrodes were positioned as indicated
by Colebatch et al. [27]; during the recording the patient
was instructed to raise his head from the pillow to activate
the bilateral sternocleidomastoid muscle. A stimulus at a
frequency of 500Hz was presented to one ear through a
headphone at an intensity of 130 dB; the analysis window
was 100ms. Analysis was conducted on the amplitudes of
the first positive–negative peak, P13–N23, and peak latencies
of P13 and N23. The average of two measurements was
taken to define amplitudes and latencies [28]. Caloric test
was performed according to the Fitzgerald-Hallpike method:
each ear was water-irrigated for 40 seconds at temperatures
of 44∘C and 30∘C.
Diagnosis was completed through CT scan and MRI.
CT scan was performed without contrast administration
and using a helical acquisition technique: the temporal
bone images were acquired with axial planes and evaluated
on oblique, coronal, and sagittal planes. MRI images were
obtained on a 1.5-T superconducting MR scanner (Philips
INTERA). Targeted imaging of the vascular and nervous
structures of the pontocerebellar angle were performed using
axial 3-dimensional heavily T2-weighted images (3D TSE
T2 WIs) and TSE T1 weighted images (TSE T1 WIs) with a
slice thickness of 0.5mm and 3mm, respectively. Coronal T2
WIs were obtained using orthogonal planes to the long axis
of the internal auditory canal and with oblique parasagittal
and paracoronal planes (MPR reformatted images—slice
thickness ranging between 0.4mm and 3mm).
PTA revealed a threshold of 95.9 dB and an ABG of
42.5 dB in the left ear and a threshold of 97.70 dB and an
ABG of 17.5 dB in the right ear (Figure 1(a)). TEOAEs,
DPOAEs, and VEMPs were absent bilaterally. Tympanome-
try presented a Type A tympanogram. The caloric labyrinth
stimulation revealed bilateral normoreflexia. Audiological
tests and history of bilateral fluctuating sensorineural hearing
loss, more evident in the right side, and vertigo attacks were
suggestive for a diagnosis of EH. Temporal bone CT revealed
a 2.2mm dilatation of the left vestibular aqueduct. A small
(diameter: 2.6mm) area of altered signal intensity was evi-
dent in the left vestibule (Figure 2). Enlarged endolymphatic
ducts and sacs were seen onMRI (Figure 3) in the left side. CT
and MRI images were also evaluated for cochlear dysplasia,
cochlear-vestibular dysplasia, andmodiolar hypoplasia based
on published criteria [20, 29]. No additional inner ear
malformations were observed in this patient.
Under local anesthesia (10% lidocaine, spray), patient was
treated with bilateral intratympanic prednisone (5mg/mL)
once a day for three consecutive days, followed by 7 days
of treatment suspension and additional 3 days of injections,
using a 25-gauge spinal needle inserted in the posteroinferior
portion of the tympanic membrane. Pure tone audiometry,
TEAOEs, DPOAEs, tympanometry, VEMPs, and caloric
test were repeated after 8 days and one, three, and six
months. PTA values one month after the first injection were
86.8 dB with an ABG of 28.75 dB in the left ear and 62.7 dB
with an ABG of 12.5 dB in the right ear (Figure 1(b)).
Threshold did not significantly change at all follow-up time
points. TEOAEs, DPOAEs, and VEMPs were bilaterally
absent before and after intratympanic treatment. The caloric
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Figure 1: Pure tone audiometry results, before (a) and one month after (b) the intratympanic treatment. A bilateral hearing improvement,
significantly more evident in the right side, is noticeable after treatment.
Figure 2: CT scan results: the endolymphatic duct and sac in the left
side are larger (2.2mm) than in the right side (1.4mm).
labyrinth stimulation revealed a bilateral normoreflexia at all
time points.
3. Discussion
The causes of EVA syndrome are currently unknown. Dif-
ferent authors have hypothesized a blockade of inner ear
development during the fifth week of embryonic life, when
its growth is maximal, and an abnormal communication
between the subarachnoid space and the inner ear [13].
Clinical manifestations in EVA syndrome are variable,
suggesting that it may be related not only to anatomical
abnormalities of the inner ear, but also to the physiology
of the auditory and vestibular systems. In this case report,
there are two important aspects to consider that, if missed,
could lead to an incorrect diagnosis: the patient had a long-
time history of bilateral hearing fluctuation and episodes of
vertigo, suggestive for a diagnosis of bilateral EH. However,
fluctuation in hearing can also be found in EVA patients,
often following relatively minor head trauma; such fluctua-
tions however are not usually associated with vertigo attacks
[30]. In this patient, the long-time history of typical asso-
ciation of hearing fluctuation and vertigo crisis, associated
with previously collected audiological evidence, including
a positive glycerol test for EH and positive response to
systemic and intratympanic therapy, can reasonably confirm
the diagnosis of coexistent bilateral EH. The second element
is the presence of bilateral hearing loss in a case of unilateral
EVA. In such cases, hearing loss in the ear contralateral to the
EVA is common; several authors reported that unilateral EVA
may also present a contralateral hearing loss, suggesting that
unilateral EVA may be a bilateral process despite unilateral
imaging finding [30]. In this patient, however, while radi-
ological evidence confirmed the diagnosis of left side EVA,
audiological tests and, especially, history were also suggestive
for a concomitant bilateral EH.
Although EVA is a congenital disorder, some authors
proposed that hearing loss in EVA syndrome is acquired as
it has been reported to be triggered by minor head trauma
[31]. There is no agreement on the association between head
trauma and hearing loss in EVA. Different authors suggested
that cochlear injury could result from chemical damage
to the organ of Corti by hyperosmolar endolymphatic sac
content following reflux from the sac after head injury and
by failure of the stria vascularis ion exchange mechanism
[31, 32]. Another possible explanation could be found in a
direct impact to the cochlea, causing a transient shockwave
on the patient aqueduct followed by intracochlear mem-
brane rupture, especially when abnormalities are present at
this level [21]. A recent systematic review on progressive
hearing loss and head trauma in EVA found that 39.6%
of patients with SNHL in EVA syndrome report a history
of head injury, and about 12% report a trauma-associated
progression, concluding that although long-term progressive
hearing loss is common in EVA syndrome, its association
with head trauma is not strongly supported [31]. However,
further histopathological studies are necessary for definitive
conclusions.
The overall incidence of vestibular alterations in pa-
tients with EVA syndrome ranges from 12 to 86% [33].
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Figure 3:MRI. TSET1 (a) andT2WIs (b) images.The area of altered signal intensity in the left utricle is clearly definedwhile no abnormalities
are seen in the right utricle.
Emmett reviewed 26 patients with EVA syndrome, reporting
a 12% incidence of vestibular symptoms [7]; Jackler et al.
[34] reported a 30% incidence of vestibular symptoms in
a series of 17 patients; Berrettini et al. [35] found that
13/15 patients (86%) presented vestibular hypofunction or
areflexia; Sugiura et al. [14] examined 17 patients with EVA
syndrome, 12 of them (71%) referred with episodic vertigo.
Vestibular dysfunction etiology is still unclear; it has been
hypothesized that the reflux of hyperosmotic fluid into the
basal end of the cochlear duct may elicit vertigo, while
degeneration of vestibular hair cells due to osmotic and
chemical imbalance may be another mechanism of injury [9,
28, 33]. Sheykholeslami et al. [36] measured VEMPs in three
patients with an EVA syndrome who had previously under-
gone vestibular testing with normal results and demonstrated
lower VEMP threshold scores in these patients, indicating
a possible saccular dysfunction. In our study, VEMPs were
bilaterally absent before and after intratympanic treatment
therapy showing a permanent saccular damage.
In the comparison of MRI and CT scan for the diagnosis
of an EVA syndrome, current literature suggests that both
techniques are complementary for identifying structural
alterations [31, 32]. MRI, however, presents some advantages:
in fact, since the endolymphatic sac is not normally identi-
fiable in patients without EVA, positive identification of this
structure represents an easy diagnostic method. In addition,
MRI provides a clear assessment of cochlear nerve integrity,
central nervous system abnormalities, and the presence of
nonossifying inner ear obstruction that is not evident on CT
[18, 37]. MRI has also been proposed to diagnose EH. A
study fromNaganawa et al. showed that EH can be visualized
using 3-TMRI performed 4 hours after intravenous injection
of gadolinium [38]. Recently, Sone et al. investigated the
presence of EH in subjects with EVA syndrome using 3T
MRI and correlated imaging data concerning the degree of
EH in the cochlea and the vestibule with clinical symptoms
and hearing levels in 9 patients [39]. In this case, patient
was studied using a 1.5T MRI that, due to its resolution,
was unable to confirm EH; therefore, diagnosis was based on
clinical and anamnestic data.
This patient was treated with intratympanic injection
of corticosteroids with a partial hearing restoration, more
evident in the right side, and an improvement in vertigo
symptoms. As expected, the larger benefits in hearing restora-
tion following corticosteroid treatment were seen in the
ear contralateral to EVA. One of the first reports regarding
the effects of intratympanic treatment of steroids for EH
showed an 80% improvement in vertigo [39]. Afterwards,
several studies on intratympanic treatment for EH have
been published [23, 25, 40] showing different results on
hearing and vertigo: the choice of steroids, the variability of
their concentration, and the outcome measurements could
explain the variability of the published results. Recently, Itoh
and Sakata showed a significant control of vertigo in 82%
of the treated patients after intratympanic treatment with
dexamethasone (4mg/ml, daily injection for 5 consecutive
days) [41]. In the opinion of the authors, intratympanic
injection for the treatment of labyrinthine affections such
as EH is a procedure that maximizes drug concentration
in the cochlea and minimizes systemic dissemination: the
high concentration of topic steroids in the cochlea may
justify the high percentage of remission observed in recent
experiences.
In the literature, to the best of authors’ knowledge, there is
only one case report of a patient with EVA syndrome and EH,
in which the authors hypothesized that the two conditions
may be due to a common primary dysfunction of inner
ear fluid homeostasis [42]. Although this physiopathological
common basis cannot be confirmed, it is always necessary
in patients with EVA to also investigate possible coexisting
independent inner ear disorders such as EH, especially when
a suggestive history for endolymphatic hydrops is present.
Consistently, it is always necessary to perform a thoughtful
radiological examination with CT scan and MRI in patients
with audiovestibular symptoms suggesting an inner ear dis-
order.
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Patients with a diagnosis of EVA, in the presence of
serviceable hearing, should be advised to avoid contact sports
or activities that increase intracranial pressure to prevent
hearing loss or further hearing deterioration. Intratympanic
treatment with steroids is a safe and well-tolerated procedure
that has demonstrated its efficacy in hearing, tinnitus, and
vertigo control in EH.
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